Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
This study has been completed.
Study NCT00039858   Information provided by Encysive Pharmaceuticals
First Received: June 13, 2002   Last Updated: January 10, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thrombocytopenia
Thrombosis
More general conditions related to this trial
Blood Platelet Disorders
Cardiovascular Diseases
Embolism and Thrombosis
Hematologic Diseases
Vascular Diseases
Interventions listed in this trial
Argatroban
Additional drug interventions recognized in this trial
Anticoagulants
Heparin
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Encysive Pharmaceuticals
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services